• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-HCC2 通过抑制增强子 I/X 启动子的活性来抑制乙型肝炎病毒复制。

miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.

机构信息

Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, No. 22 Qi-Xiang-Tai Road, Tianjin, 300070, China.

出版信息

Arch Virol. 2023 Oct 27;168(11):282. doi: 10.1007/s00705-023-05899-z.

DOI:10.1007/s00705-023-05899-z
PMID:37889339
Abstract

miR-HCC2 has been reported to markedly promote the growth, metastasis, and stemness of hepatocellular carcinoma (HCC) cells in vitro and in vivo. Deep sequencing showed that miR-HCC2 was significantly upregulated in hepatitis B virus (HBV)-positive (HBV) HCC tissue samples compared with HBV-negative (HBV) HCC tissue samples. miR-HCC2 expression was further evaluated in HCC tissues and cells, and the expression of miR-HCC2 was found to be significantly higher in HBV HCC tissues and cells than in HBV HCC tissues and cells, suggesting that high miR-HCC2 expression could be induced by HBV infection. To explore the relationship between miR-HCC2 and HBV, we investigated the effect of miR-HCC2 on HBV antigen expression, transcription, and replication. We found that miR-HCC2 was involved in the negative feedback regulation of HBV replication. Further mechanistic studies revealed that miR-HCC2 suppressed HBV replication by inhibiting the activity of the enhancer I/X promoter. Our study demonstrates the effect of the inhibition of miR-HCC2 on HBV gene expression and replication, which can help to illustrate the complex regulatory network involving host miRNAs and HBV.

摘要

miR-HCC2 已被报道可显著促进肝癌(HCC)细胞的体外和体内生长、转移和干细胞特性。深度测序显示,miR-HCC2 在乙型肝炎病毒(HBV)阳性(HBV)HCC 组织样本中明显上调,而在 HBV 阴性(HBV)HCC 组织样本中下调。miR-HCC2 的表达在 HCC 组织和细胞中进一步进行了评估,发现 miR-HCC2 在 HBV HCC 组织和细胞中的表达明显高于 HBV HCC 组织和细胞,表明高 miR-HCC2 表达可能是由 HBV 感染诱导的。为了探讨 miR-HCC2 与 HBV 之间的关系,我们研究了 miR-HCC2 对 HBV 抗原表达、转录和复制的影响。我们发现 miR-HCC2 参与了 HBV 复制的负反馈调节。进一步的机制研究表明,miR-HCC2 通过抑制增强子 I/X 启动子的活性抑制 HBV 复制。我们的研究证明了抑制 miR-HCC2 对 HBV 基因表达和复制的影响,这有助于阐明涉及宿主 miRNAs 和 HBV 的复杂调控网络。

相似文献

1
miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.miR-HCC2 通过抑制增强子 I/X 启动子的活性来抑制乙型肝炎病毒复制。
Arch Virol. 2023 Oct 27;168(11):282. doi: 10.1007/s00705-023-05899-z.
2
MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.微小 RNA-802 通过调节肝癌中 SMARCE1 的表达诱导乙型肝炎病毒复制和复制。
Cell Death Dis. 2019 Oct 14;10(10):783. doi: 10.1038/s41419-019-1999-x.
3
MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.miR-185-5p 通过靶向 Elk1 抑制肝癌细胞中 HBV 基因的表达。
Life Sci. 2018 Nov 15;213:9-17. doi: 10.1016/j.lfs.2018.10.016. Epub 2018 Oct 9.
4
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.微小 RNA-210-3p 在乙型肝炎病毒相关肝细胞癌中的作用。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G401-G409. doi: 10.1152/ajpgi.00269.2019. Epub 2020 Jan 6.
5
Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.乙型肝炎病毒通过 LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug 通路促进中国男性肝癌患者的增殖和转移。
Exp Cell Res. 2018 Sep 1;370(1):174-188. doi: 10.1016/j.yexcr.2018.06.020. Epub 2018 Jun 19.
6
miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.微小RNA-29a通过靶向肝癌中的SMARCE1促进乙型肝炎病毒复制和表达。
World J Gastroenterol. 2017 Jul 7;23(25):4569-4578. doi: 10.3748/wjg.v23.i25.4569.
7
Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.HBV 通过上调 DARS2 促进肝癌发生发展的分子机制研究:miR-30e-5p/MAPK/NFAT5 通路。
J Exp Clin Cancer Res. 2017 Oct 19;36(1):148. doi: 10.1186/s13046-017-0618-x.
8
MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1.微小 RNA-1271 通过与 CCNA1 结合在 AMPK 信号通路中作为乙型肝炎病毒相关肝细胞癌的潜在肿瘤抑制因子发挥作用。
J Cell Physiol. 2019 Apr;234(4):3555-3569. doi: 10.1002/jcp.26955. Epub 2018 Nov 22.
9
Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.在乙型肝炎病毒相关的肝癌细胞中上调的miR-331-3p,通过靶向ING5促进肝癌细胞的增殖。
Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.
10
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.微小RNA-106b促进乙型肝炎病毒相关肝细胞癌的癌症进展。
World J Gastroenterol. 2016 Jun 14;22(22):5183-92. doi: 10.3748/wjg.v22.i22.5183.

本文引用的文献

1
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.潜在的血浆生物标志物:miRNA-29c、miRNA-21 和 miRNA-155 在肝癌患者的临床进展中的作用。
PLoS One. 2022 Feb 14;17(2):e0263298. doi: 10.1371/journal.pone.0263298. eCollection 2022.
2
Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines.富含人肝细胞的 miRNA-192-3p 通过靶向肝细胞系中的 ZNF143 抑制 Akt/mTOR 信号通路促进 HBV 复制。
Emerg Microbes Infect. 2022 Dec;11(1):616-628. doi: 10.1080/22221751.2022.2037393.
3
Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11.
阴阳 1 和 HBx 蛋白通过介导 cccDNA 微染色体与细胞染色体 19p13.11 的空间相互作用来激活 HBV 转录。
Emerg Microbes Infect. 2020 Dec;9(1):2455-2464. doi: 10.1080/22221751.2020.1840311.
4
MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.MiR-HCC2上调BAMBI和ELMO1表达以促进肝癌细胞增殖和上皮-间质转化
J Cancer. 2019 Jun 9;10(15):3407-3419. doi: 10.7150/jca.30858. eCollection 2019.
5
miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4.miRNA-548ah 通过靶向组蛋白去乙酰化酶 4 促进乙型肝炎病毒的复制和表达。
Life Sci. 2019 Feb 15;219:199-208. doi: 10.1016/j.lfs.2018.12.057. Epub 2019 Jan 4.
6
Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)相关肝细胞癌的流行病学
Open Virol J. 2018 Feb 28;12:26-32. doi: 10.2174/1874357901812010026. eCollection 2018.
7
MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis.微小 RNA-125b-5p 通过 LIN28B/let-7 轴介导乙型肝炎病毒复制的转录后调控。
RNA Biol. 2017 Oct 3;14(10):1389-1398. doi: 10.1080/15476286.2017.1293770. Epub 2017 Mar 7.
8
miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA.miR-370 通过靶向核因子 IA 抑制 HBV 基因表达和复制。
J Med Virol. 2017 May;89(5):834-844. doi: 10.1002/jmv.24695. Epub 2016 Oct 3.
9
Mechanisms of HBV-induced hepatocellular carcinoma.HBV 诱导肝细胞癌的机制。
J Hepatol. 2016 Apr;64(1 Suppl):S84-S101. doi: 10.1016/j.jhep.2016.02.021.
10
Viral life cycle of hepatitis B virus: Host factors and druggable targets.乙型肝炎病毒的病毒生命周期:宿主因素与可成药靶点。
Hepatol Res. 2016 Aug;46(9):871-7. doi: 10.1111/hepr.12650. Epub 2016 Feb 16.